Top Event
Top
Events
Market Entry
Biotechnology
Delegation
Transatlantic Medical Biotech-modified Symposium
Event Start
10/10/2024 · 16:00
Event End
10/10/2024 · 21:00
PST
Registration

Register here!

Fostering innovation and transformative technologies

Discover how Medical Biotechnology is Advancing Modern Healthcare between the US and Germany!

Sign up today!

 

The largest biotech hub in the US West Coast is located in the San Francisco Bay Area. With a concentration of world-renowned universities, research institutions, and a thriving startup ecosystem, the Bay Area offers a unique advantage for biotech companies to collaborate, access top-tier talent, and benefit from a supportive regulatory environment, driving the rapid development and commercialization of cutting-edge biotechnologies. This vibrant ecosystem continues to attract investment and shape the future of biotechnology on a global scale.

Germany also plays an eminent role in the biotech market. Its focus on education and research is exemplified by world-class institutions like the Max Planck Society, fostering breakthroughs in molecular biology and genetics. Beside the presence of leading pharmaceutical companies, Germany's clear regulatory framework and emphasis on ethical considerations contribute to a favorable ecosystem for biotech advancements.

The Transatlantic Medical Biotech Symposium aims to foster meaningful partnerships and knowledge exchange between the vibrant biotechnology communities in California and Germany. This conference will serve as a platform for industry professionals, researchers, entrepreneurs, and investors to come together, share insights, discuss cutting-edge advancements, and explore opportunities for collaboration.

Some guiding key questions:

  • What are the latest breakthroughs and technological innovations and their impact on healthcare?
  • How does funding play a role in delivering transformative applications to real-world patient care and medical practices?
  • To what extent do researchers, practitioners, and policymakers need to keep in mind the ethical dilemmas and regulatory challenges?
  • How can universities and research facilities improve the overarching landscape of biotechnology development in Silicon Valley? How can Germany contribute to this? 

What will be your takeaways?

  • Ways that AI and Big Data can be used to gain new approaches in manufacturing and developing drug and therapeutic treatments
  • The depth of investment being put towards medical advancement to improve healthcare for future generations
  • How to maintain a balance between innovation and ethical considerations, ensuring patient welfare, and creating a robust regulatory framework that fosters responsible innovation
  • How close coordination of research facilities and Silicon Valley's futuristic atmosphere enables quicker and more efficient development of life-saving medical care
  • and more...

Register here!

With the support of: